Cancer control research in the North Central Cancer Treatment Group (NCCTG)
Loprinzi, C.L.; Miser, A.W.; Kardinal, C.; Everson, L.K.; Ahlquist, D.A.; Dose, A.M.; Moertel, C.G.
Progress in Clinical and Biological Research 293: 345-353
1989
ISSN/ISBN: 0361-7742 PMID: 2657773 Document Number: 334861
Document emailed within 1 workday
Related Documents
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Stone-Wiggins, B.; Porterfield, D. 2001: The North Carolina Cancer Control Program. Caring for uninsured and low-income patients with cancer North Carolina Medical Journal 62(5): 248-251
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Napalkov, N. 1974: Research activities of the cancer unit of the World Health Organization in cancer control National Cancer Institute Monograph 40: 47-50
1970: Present state of early diagnosis in bronchial carcinoma. Results of the coordinating program of the German Central Committee for the Fight Against Cancer and Cancer Research Deutsche Medizinische Wochenschrift 95(2): 53-59
Smith, P.H.; de Pauw, M.; Sylvester, R. 1984: The urological group of the EORTC (European Organization for Research on the Treatment of Cancer), 1976-1984 Archivos Espanoles de Urologia 37 Suppl. 2: 713-723
Kluge, E.; Ebeling, K. 1985: Clinical cancer documentation of the Central Institute for Cancer Research of the Academy of Sciences of the German Democratic Republic, Berlin-Buch--tasks, organization and usefulness Archiv für Geschwulstforschung 55(4): 265-278
Axelsson, C.K.; Andersen, J.A.; Andersen, K.W.; Blichert-Toft, M.; Dombernowsky, P.; Hansen, M.; Krag, C.; Mouridsen, H.T.; Overgaard, M.; Rasmussen, B.B. 1991: Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group) Ugeskrift for Laeger 153(33): 2276-2279
1997: Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK) European Journal of Surgery 163(9): 693-701
Moraska, A.R.; Atherton, P.J.; Szydlo, D.W.; Barton, D.L.; Stella, P.J.; Rowland, K.M.; Schaefer, P.L.; Krook, J.; Bearden, J.D.; Loprinzi, C.L. 2010: Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB Journal of Supportive Oncology 8(3): 128-132
Sperb, R.A.; von Rohr, A.; Ratschiller, D.; Bacchi, M.; Tichelli, A.; Hess, U.; Cerny, T.; Tobler, A.; Betticher, D.C. 1998: 2-CDA in treatment of hairy cell leukemia: a comparison between intravenous and subcutaneous administration. Swiss Study Group of Applied Cancer Research Schweizerische Medizinische Wochenschrift 128(42): 1593-1597
Stratton, J.F.; Buckley, C.H.; Lowe, D.; Ponder, B.A. 1999: Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group Journal of the National Cancer Institute 91(7): 626-628
Metzger, U.; Laffer, U.; Egeli, R.; Barras, J.; Martinoli, S.; Müller, W.; Arma, S.; Bär, H.U.; Schweizer, W.; Aeberhard, P. 1989: Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81) Helvetica Chirurgica Acta 56(4): 455-460
Bollack, C.; Jacqmin, D.; Splinter, T.A.; De Pauw, M. 1988: Non-adjuvant chemotherapy of bladder neoplasms stage T3-4 using NO-x and MO. Preliminary results of the urogenital study group of the European Organization for Research and Treatment of Cancer Casopis Lekaru Ceskych 127(35): 1098-1100
Fowler, W.C.; Cutchin, L.M.; Crocker, D.L.; Hall, J.B.; Begun, J.W.; Freeman, A.C.; Hulka, B.S.; Kaluzny, A.D.; O'Keefe, S.P.; Symons, M.J.; Lee, Y.Y. 1983: Cancer control and community physicians in North Carolina North Carolina Medical Journal 44(6): 357-361
1989: Diagnosis and first-line treatment of patients with lung cancer in Italian general hospitals. G.I.V.I.O. (Interdisciplinary Group for Cancer Evaluation) Tumori 75(2): 163-167
Deem, V.W.; Nelson, D.; Fitz-Simons, T.; Johnson, K.; Herring, E. 2014: The North Carolina Breast and Cervical Cancer Control Program North Carolina Medical Journal 75(2): 149-150
Röttinger, E.M. 1995: Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(5): 303-304
Buesa, J.M.; Mouridsen, H.T.; Santoro, A.; Somers, R.; Bramwell, V.; van Oosterom, A.T.; Wagener, T.; Vendrik, C.; Thomas, D. 1984: Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase Ii trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Cancer Treatment Reports 68(4): 683-684